王久存

基本信息

职称:教授
电话:021-51630606
邮箱: jcwang@fudan.edu.cn
地址:复旦大学生命科学学院 A603室

个人简介

实验室网站:http://klca.fudan.edu.cn/
女,博士,博士生导师,复旦大学风湿、免疫、过敏性疾病研究中心副主任,现代人类学教育部重点实验室副主任,硬皮病临床与研究国际协作网(InSCAR)副理事长及执行委员,上海市免疫学会风湿免疫专业委员会委员。1988及1991年分获复旦大学生物系学士及硕士学位,1999年获日本福井大学生物应用化学专业博士学位。2007-2008年于美国德克萨斯大学休斯顿健康科学中心访问研究。1991-1994年任复旦大学生命科学学院助教、讲师。2000起任复旦大学生命科学学院讲师、副教授、教授。正在承担国家国际科技合作专项、国家自然科学基金等课题,作为Site-PI(地区PI)承担NIH-U01项目,领导中国地区硬皮病及强直性脊柱炎HLA区域精细结构分析。

Deputy Director of Institute of Rheumatology, Immunology and Allergy, Fudan University; Deputy Director, Ministry of Education Key Laboratory of Contemporary Anthropology; Associate Board Director and Excecutive Committee Member of International Network of Scleroderma Clinical Care and Research (inSCAR). Undergraduate study at the Dept. of Biology, Fudan University from 1984-1988, B.S. degree in Biology in 1988, and M.S. degree in biology in 1991 from Fudan University. Ph.D in applied biochemistry from Fukui University, Japan in 1999. Research scholar at the University of Texas Health science Center at Houston from 2007-2008. Assistant Professor at Fudan University from 1991-1994. Assistant/Associate Professor/Professor at the School of Life Sciences, Fudan University since 2000. Leading one program of International S & T Cooperation, and NSFC Projects. As a Site PI, lead the Chinese effort in one NIH-U01 project entitled “Studies of HLA Region Genomics in Systemic Sclerosis and Ankylosing Spondylitis”.

 

主要研究方向 (Research Interests)

硬皮病、强直性脊柱炎、痛风等风湿、免疫性疾病的分子流行病学研究及分子致病机理研究,肺癌等肿瘤致病机理的遗传学及表观遗传学研究。Works on the molecular epidemiology and molecular mechanism of scleroderma, ankylosing spondilitis, and gout, as well as the genetic and epigenetic research of lung cancer, and etc.

 

获奖情况 (Awards)

2004年度上海市科技进步奖一等奖[the first place Award of the Science and Technology Advancement of Shanghai];

2003-2004年度复旦大学三八红旗手 (Outstanding Women of Fudan University in 2003-2004);

复旦大学风湿、免疫、过敏性疾病研究中心2012年度“精英奖” (Elite Award in 2012 of the Institute of Rheumatology, Immunology and Allergy, Fudan University).

 

代表性成果

  1. Guo S, Tan L, Pu W, Wu J, Xu K, Wu J, Li Q, Ma Y, Xu J, Jin L, Wang J*. Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer. Clin Epigenetics. 2014 Mar 24;6(1):5.
  2. Wang X, Wang L, Guo S, Bao Y, Ma Y, Yan F, Xu K, Xu Z, Jin L, Lu D, Xu J, Wang JC*. Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small cell lung cancers. FASEB J. 2013 Oct;27(10):4194-4203.
  3. Wang YL, Feng SH, Guo SC, Wei WJ, Li DS, Wang Y, Wang XF, Wang ZY, Ma YY, Jin L, Ji QH, Wang JC*. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J Med Genet. 2013 Jul 11.
  4. Wu J, Liu J, Zhou Y, Ying J, Zou H, Guo S, Wang L, Zhao N, Hu J, Lu D, Jin L, Li Q, Wang JC*. Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: A systematic review and meta-analysis. Clin Cancer Res. 2012; 18(14):3972-3981.
  5. Wang JC, Lai S, Guo X, Zhang X, de Crombrugghe B, Arnett FC, Zhou X. Attenuation of fibrosis in vitro and in vivo with Sparc siRNA. Arthritis Res Ther. 2010; 12(2):R60.
Copyright © 2014 School of Life Sciences Fudan University All Rights Reserved
联系地址:上海市淞沪路2005号